Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment. [electronic resource]
Producer: 20090911Description: 6216-22 p. digitalISSN:- 1538-7445
- Benzamides
- Cell Line, Tumor
- Chondrosarcoma -- drug therapy
- Dasatinib
- Glycogen Synthase Kinase 3 -- metabolism
- Glycogen Synthase Kinase 3 beta
- Humans
- Imatinib Mesylate
- Jurkat Cells
- MAP Kinase Signaling System -- drug effects
- Piperazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyrimidines -- pharmacology
- Thiazoles -- pharmacology
- raf Kinases -- metabolism
- ras Proteins -- metabolism
- src-Family Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.